Funded Hospitals and Health Care Startups
Across the 16 most recent hospital and health care startup rounds shown, the largest disclosed amount is Medix Infusion’s $35M Series B on 2023-01-09, whic…
Across the 16 most recent hospital and health care startup rounds shown, the largest disclosed amount is Medix Infusion’s $35M Series B on 2023-01-09, which materially dwarfs nearly all other disclosed rounds (many are in the low single-digit millions, with several at $2M). The other clear outlier behavior is the disclosure mix: 2 entries are undisclosed (KeyOps on 2023-06-27, and Well iQ on 2022-12-21), while 9 entries carry “Series Unknown,” including Holaglow ($2M, 2024-09-17) and Bluem Nursing ($120K, 2024-05-10).
Date-wise, the list spans 2022-11-03 through the most recent 2025-03-03, with a dense cluster in spring 2024: on 2024-05-10 alone there are two $2M/$120K rounds (Sendaride and Bluem Nursing), followed by another Seed on 2024-05-02 (AISAP, $13M) and nearby entries into mid-May. Geographically, the rounds are widely distributed, but several U.S. states appear repeatedly (California and Ohio each show up more than once), while non-U.S. entries are concentrated in single-country placements such as Israel (AISAP, 2024-05-02) and Spain (Holaglow, 2024-09-17).
Most recent rounds
16 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Hospitals and Health Care list, and how does it compare to the rest of the disclosed amounts?
Medix Infusion’s $35M (Series B, 2023-01-09) stands well above the other disclosed amounts, where most entries are far lower—e.g., Positive Development’s $37M is not present here (it is present at $37M on 2022-11-09) so the correct comparison is that $35M is the largest disclosed value while the next-largest disclosed amounts include AISAP at $13M (2024-05-02) and several $4M–$6M rounds like Legion Health ($4M, 2022-11-09) and InpharmD ($6M, 2023-12-07).
Do any rounds cluster tightly by time, particularly around 2024?
Yes. Spring 2024 is concentrated: Sendaride ($2M, 2024-05-10) and Bluem Nursing ($120K, 2024-05-10) share the exact date, with AISAP closing on 2024-05-02 ($13M) and additional late-2024 activity including Holaglow on 2024-09-17 ($2M).
How heavy is the “Series Unknown” and undisclosed pattern in this segment?
Out of 16 rows, 9 list “Series Unknown” (including Holaglow on 2024-09-17 at $2M and Legion Health on 2022-11-09 at $4M), and 2 are explicitly “undisclosed” amounts (KeyOps, 2023-06-27; Well iQ, 2022-12-21). The remaining 5 have specified stages and disclosed amounts, such as Medix Infusion (Series B, $35M on 2023-01-09).
Which stage labels dominate among the entries where the stage is specified?
Among specified stages, Series B shows up more than once with large disclosed checks: Medix Infusion ($35M, 2023-01-09) and Fathom ($46M, 2022-11-09). Seed also appears repeatedly with meaningful variation—from $120K (Bluem Nursing, 2024-05-10) up to $13M (AISAP, 2024-05-02).
Are there geographic patterns worth flagging, or is the list broadly dispersed?
The dispersion is real, but the U.S. isn’t uniform: California appears at least twice (Fathom in San Francisco at $46M on 2022-11-09; Proactive Diagnostics in Thousand Oaks at $2M on 2022-11-03), and Ohio also repeats (Nexus Bedside in Cleveland at $3M on 2025-03-03; Positive Development in Washington, District of Columbia, is separate, but Legion Health is Texas while High Enroll is Cincinnati, Ohio at $140K on 2022-11-15). Non-U.S. entries are present but mostly single-location snapshots, such as Holaglow in Spain (2024-09-17, $2M) and AISAP in Israel (2024-05-02, $13M).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.